Using DAPI for nuclear staining and specific antibodies for GD3, GM3, and cleaved caspase 3, we observed a dose-dependent decrease in the expression of all three in quercetin-treated melanoma cells undergoing apoptosis. The gene discussed is CASP3; the disease is melanoma.